We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

178 hedge funds and large institutions have $792M invested in Impax Laboratories, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 47

43% more call options, than puts

Call options by funds: $2.75M | Put options by funds: $1.93M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less capital invested

Capital invested by funds: $795M → $792M (-$3.15M)

10% less funds holding

Funds holding: 198 → 178 (-20)

30% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 44

Holders
178
Holders Change
-20
Holders Change %
-10.1%
% of All Funds
4.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
75
Reduced
47
Closed
44
Calls
$2.75M
Puts
$1.93M
Net Calls
+$823K
Net Calls Change
+$1.46M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$131M
2
Millennium Management
Millennium Management
New York
+$26.7M
3
Citadel Advisors
Citadel Advisors
Florida
+$18.5M
4
FCM
Frontier Capital Management
Massachusetts
+$13.4M
5
SIG
Senator Investment Group
New York
+$13.3M

Top Sellers

Rank Fund Capital Flow
1
HP
Hound Partners
New York
-$58.8M
2
Franklin Resources
Franklin Resources
California
-$28.8M
3
Victory Capital Management
Victory Capital Management
Texas
-$16.9M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$15.9M
5
NIMC
NWQ Investment Management Company
California
-$13.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
101
Atika Capital Management
New York
$499K +$477K +39,500 New
UBS AM
102
UBS AM
Illinois
$487K +$279K +23,092 +150%
ASRS
103
Arizona State Retirement System
Arizona
$485K +$3.62K +300 +0.8%
Skandinaviska Enskilda Banken (SEB)
104
Skandinaviska Enskilda Banken (SEB)
Sweden
$478K -$3.08M -255,300 -87%
T. Rowe Price Associates
105
T. Rowe Price Associates
Maryland
$468K +$154K +12,764 +53%
VOYA Investment Management
106
VOYA Investment Management
Georgia
$398K -$15.9M -1,319,443 -98%
UBS Group
107
UBS Group
Switzerland
$387K -$178K -14,726 -32%
LSERS
108
Louisiana State Employees Retirement System
Louisiana
$380K +$3.62K +300 +1%
JAM
109
JW Asset Management
Florida
$380K +$362K +30,000 New
AG
110
Aperio Group
California
$366K +$137K +11,350 +65%
CCMH
111
Cornerstone Capital Management Holdings
New York
$350K -$2.44M -202,386 -88%
AQR Capital Management
112
AQR Capital Management
Connecticut
$350K +$26.7K +2,212 +9%
TRSOTSOK
113
Teachers Retirement System of the State of Kentucky
Kentucky
$319K – – –
LSV Asset Management
114
LSV Asset Management
Illinois
$304K – – –
Tudor Investment Corp
115
Tudor Investment Corp
Connecticut
$282K -$668K -55,312 -71%
HIMCH
116
Hartford Investment Management Co (HIMCO)
Connecticut
$262K -$38K -3,150 -13%
PA
117
Profund Advisors
Maryland
$243K -$78.5K -6,500 -25%
TAM
118
Tocqueville Asset Management
New York
$242K – – –
CAM
119
Capstone Asset Management
Texas
$238K -$24K -1,990 -10%
MSA
120
Mason Street Advisors
Wisconsin
$218K +$13.3K +1,101 +7%
MERSOM
121
Municipal Employees' Retirement System of Michigan
Michigan
$214K +$3.38K +280 +2%
PI
122
Putnam Investments
Massachusetts
$191K -$292K -24,175 -61%
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
$190K +$19.2K +1,588 +12%
SBA
124
Seven Bridges Advisors
New York
$184K -$310K -25,631 -64%
LCM
125
Laurion Capital Management
New York
$183K +$175K +14,500 New
3 4
5
6 7

IPXL Hedge Fund Activity: Q1 2017 in Review

178 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q1 2017, worth a combined $792M — down 0.4% from $795M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IPXL and 31 opened new positions — a net loss of 13 holders — while 47 trimmed existing stakes and 75 added.

The largest buyer was BlackRock, adding an estimated $131M. The largest seller was Hound Partners, exiting entirely with an estimated $58.8M sold.

  • 178 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q1 2017, down from 198 in Q4 2016.
  • Funds reported $792M of Impax Laboratories, Inc. stock for Q1 2017, down 0.4% quarter-over-quarter.
  • 31 funds opened new Impax Laboratories, Inc. positions in Q1 2017 and 44 closed out, a net change of -13 holders.
  • The largest Impax Laboratories, Inc. buyer in Q1 2017 was BlackRock, an estimated $131M added.
  • The largest Impax Laboratories, Inc. seller in Q1 2017 was Hound Partners, an estimated $58.8M sold.

Based on aggregated 13F filings for Q1 2017.